Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Serine for Schizophrenia Prodrome
NCT00826202Phase 2Completed
- Sponsor
- Nathan S. Kline Institute for Psychiatric Research
- Start
- Mar 2009
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of d-serine in schizophrenia, sponsored by Nathan S. Kline Institute for Psychiatric Research. Started Mar 2009; status: completed.
02
Drugs
d-serine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00826202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00826202.